Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.69 is 36% above its 5-year average of 3.44, around the middle of its 5-year range (0.00–7.16).
As of the fiscal period ended Friday, July 31, 2026. 16.37% below its 12-month average of 5.61.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 4.69.
QUICK RATIO (ACID-TEST)
4.69
QUICK RATIO (ACID-TEST) AVG TTM
5.61
QUICK RATIO (ACID-TEST) AVG 3Y
3.57
QUICK RATIO (ACID-TEST) AVG 5Y
3.44
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.37%
CURRENT VS 3Y AVG
+31.37%
CURRENT VS 5Y AVG
+36.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.30
median of 819 covered companies
CURRENT VS SECTOR MEDIAN
+42.05%
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.60B
Quick Ratio (Acid-Test)
4.69
TTM Avg
5.61
3Y Avg
3.57
5Y Avg
3.44
Market Cap
$1.61B
Quick Ratio (Acid-Test)
13.03
TTM Avg
12.96
3Y Avg
9.14
5Y Avg
8.83
Market Cap
$1.62B
Quick Ratio (Acid-Test)
2.41
TTM Avg
2.10
3Y Avg
2.35
5Y Avg
2.26
Market Cap
$1.63B
Quick Ratio (Acid-Test)
4.99
TTM Avg
16.25
3Y Avg
13.64
5Y Avg
13.64
Market Cap
$1.64B
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.43
3Y Avg
1.49
5Y Avg
1.78
Market Cap
$1.54B
Quick Ratio (Acid-Test)
15.18
TTM Avg
8.03
3Y Avg
6.72
5Y Avg
22.81
Market Cap
$1.54B
Quick Ratio (Acid-Test)
6.44
TTM Avg
4.97
3Y Avg
9.20
5Y Avg
12.38
Market Cap
$1.53B
Quick Ratio (Acid-Test)
7.69
TTM Avg
5.54
3Y Avg
6.46
5Y Avg
10.83
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.60B | 4.69 | 5.61 | 3.57 | 3.44 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 13.03 | 12.96 | 9.14 | 8.83 |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 1.43 | 1.22 | 1.59 | 1.63 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 2.41 | 2.10 | 2.35 | 2.26 |
| Septerna Inc (SEPN)vs › | $1.63B | 4.99 | 16.25 | 13.64 | 13.64 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 1.07 | 1.43 | 1.49 | 1.78 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 15.18 | 8.03 | 6.72 | 22.81 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 6.44 | 4.97 | 9.20 | 12.38 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | 7.69 | 5.54 | 6.46 | 10.83 |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 4.96 | 2.73 | 2.17 | 2.82 |
Quick Ratio
4.69
Excludes inventory
Current Ratio
4.69
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 4.69 |
| 2026-04-30 | 4.28 |
| 2026-01-31 | 7.16 |
| 2025-10-31 | 5.27 |
| 2025-07-31 | 6.63 |
| 2025-04-30 | 6.55 |
| 2025-01-31 | 1.65 |
| 2024-10-31 | 2.67 |
| 2024-07-31 | 0.00 |
| 2024-04-30 | 0.35 |
| 2024-01-31 | 0.00 |
| 2021-07-31 | 2.00 |
